Dai Zhongying, Ma Yuanyuan, Li Qiang
Department of Radiation Medical Physics, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Front Public Health. 2020 Dec 1;8:602776. doi: 10.3389/fpubh.2020.602776. eCollection 2020.
Since 2019, China has been the second largest medical device market in the world. At present, high-end radiotherapy equipment such as particle therapy system has a huge market potential due to the grim situation of cancer prevention and control and the growth of people's wealth in China. However, China's MedTech industry, especially the particle therapy equipment field, still faces the influence of policy, fluctuation of market demand, strengthening of industry supervision, and even geopolitical realities. This paper reviews the market prospect of particle therapy medical devices from the perspective of China's medical device policy and demand information analysis, which is conducive to the research on the industrial layout of particle therapy medical physics, and also helps high-performance medical device manufacturers to expand their business visions. MedTech manufacturers should actively adjust their business strategy and implement scientific and technological innovation on the basis of compliance with industry regulatory requirements in order to seize opportunities from challenges and gain profits growth.
自2019年以来，中国一直是全球第二大医疗器械市场。目前，由于中国癌症防控形势严峻以及民众财富增长，粒子治疗系统等高端放疗设备具有巨大的市场潜力。然而，中国医疗器械行业，尤其是粒子治疗设备领域，仍面临政策影响、市场需求波动、行业监管加强乃至地缘政治现实等问题。本文从中国医疗器械政策及需求信息分析的角度，对粒子治疗医疗器械的市场前景进行综述，这有利于粒子治疗医学物理的产业布局研究，也有助于高性能医疗器械制造商拓展商业视野。医疗器械制造商应积极调整经营策略，并在符合行业监管要求的基础上进行科技创新，以便从挑战中抓住机遇并实现利润增长。
